Sign inJoin waitlistJoin the waitlist

Adam Olszewski

Associate Program Director · Rhode Island Hospital/Brown University Health

Credentials: · · · · ·

History

Rhode Island Hospital/Brown University Health
Present
Alpert Medical School
Present

Roosevelt Hospital of New York
2002–2005
Medical University of Warsaw
1999–2002
Medical University of Warsaw
1995–1999

Research

Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
Science · 2000 · 580 citations
Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database
Cancer · 2013 · First of 2 authors · Corresponding · 172 citations
Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis
International Journal of Cancer · 2014 · 156 citations

Allen Seiden
135 papers
Brandi Wynne
135 papers
EB
Emerald Rose Branch
135 papers · 133 as a resident
Harpreet Bawa
135 papers · 125 as a resident
IN
Ichiro Nakano
135 papers
KD
Karl Desch
135 papers
Robert Nickerson
135 papers
Sanjay Rajagopalan
135 papers
Tyler Bold
135 papers · 106 as a resident
HM
Hayk Manuk-Hakobyan
133 papers
William Blum
124 papers
RN
Rupa Narayan
121 papers · 85 as a fellow

Grants

Stem Cells and Aging
National Institute of General Medical Sciences · P30
Project lead · $193.6K · Rhode Island Hospital
2023–2028

Clinical trials

TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
Principal investigator · Not yet recruiting · Phase 2
Brown University
2026–2030
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
Principal investigator · Recruiting · Phase 2
Brown University
2022–2027
Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma
Principal investigator · Withdrawn · Phase 2
Brown University
2019–2025
Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma
Principal investigator · Completed · Phase 1
Brown University
2017–2020